Tredje AP fonden Lowers Holdings in DaVita Inc. (NYSE:DVA)

Tredje AP fonden decreased its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 50.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,424 shares of the company's stock after selling 4,424 shares during the period. Tredje AP fonden's holdings in DaVita were worth $662,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. MML Investors Services LLC increased its holdings in shares of DaVita by 1.3% in the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company's stock worth $869,000 after buying an additional 68 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company's stock worth $133,000 after purchasing an additional 68 shares during the last quarter. Impact Partnership Wealth LLC boosted its holdings in shares of DaVita by 3.7% in the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company's stock worth $290,000 after purchasing an additional 70 shares in the last quarter. Contravisory Investment Management Inc. increased its position in shares of DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company's stock valued at $910,000 after purchasing an additional 73 shares during the last quarter. Finally, Nilsine Partners LLC raised its position in DaVita by 0.8% in the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company's stock worth $1,669,000 after purchasing an additional 92 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

Several brokerages recently commented on DVA. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Cowen reiterated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DaVita currently has an average rating of "Hold" and an average price target of $166.33.

DaVita Stock Up 0.4 %

DVA traded up $0.63 on Wednesday, hitting $150.00. The company had a trading volume of 960,920 shares, compared to its average volume of 781,249. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The stock has a fifty day simple moving average of $158.80 and a 200-day simple moving average of $157.61. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The firm has a market capitalization of $12.00 billion, a P/E ratio of 13.97, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.